Event Description

Tackling High-Cost Cell & Gene Therapies, Employer Coverage Strategies & Misaligned Incentives

This “do not miss” event is limited to 100 in-person attendees (virtual participation is available as well).

At this year’s Forum you will:

Identify what drugs are in the pipeline and why so many new ones are hitting the market
Determine how drugs get on formularies and why employers need to stay on top of their PBM
Understand how biosimilars are paid for and why copay discounts are growing
Explore the role of biomarker testing to minimize the waste of biopharmaceuticals for the wrong patient
Understand the drug supply chain and issues around importing
Hear employer challenges and opportunities in driving accountability and vigilance in managing the high cost of cell and gene therapies
Hear the latest on the new CAA regulations for transparency, fiduciary and pharmacy benefits, and their impact on employers
Determine how rebate aggregators work and how they impact drug spend
Learn critical strategies to negotiate a PBM contract and what terms and conditions should be audited

We look forward to seeing you in person* at this event! Please be assured we will conduct this program in a prudent, COVID-sensitive manner with careful attention to your health and safety. The specific protocols for attendance will be shared with registrants prior to the event.

*This program will also be available to be viewed virtually.

Alex Jung Founder, Alex Jung Consulting Former Principal, EY-Parthenon, Ernst & Young
Kim Dwyer Vice President Inspera Health
Bob Foley Vice President, Employee Benefits Mutual of Omaha
Jason Duhon Healthcare Design Manager Caterpillar, Inc.
Paul Edwards Executive Director US Oncology Merck
Amy Johnson Sr. Benefits Director, Americas Medtronic
Sandra Morris Sr. Advisor GTMRx Former Sr. Manager, Employee Benefit Design, Procter & Gamble
Jonathan E. Levitt Esq., Co-Founding Partner Frier Levitt
Randy Vogenberg, PhD Principal Institute for Integrated Healthcare
Kirby Eng, R.Ph VP, Sales and Business Development D2 Solutions
Jennifer Proudfit, R.Ph Sr. Director of Account Management, Clinical Advisor Health Strategy LLC
Tracy E. Spencer Sr. Vice President and National Practice Leader PSG Consulting
Darin Hinderman Global Health Strategy Manager, Total Rewards Caterpillar, Inc
Jason Parrott Senior VP, Strategy, Innovation, Growth and Partnerships Vida Health
Tom Sondergeld Senior Advisor McKinsey & Co

Registration Fees

Members $0
Employer Non-Members $25
Non-Members $100

HRCI Accreditation

This program is expected to be approved for 5 recertification credit hours through the HR Certification Institute (HRCI). For more information about certification or recertification, visit www.hrci.org. The use of the official seal confirms that this Program has met HRCI's criteria for re-certification credit pre-approval.